Our results highlight that EBNA2, EBV E lytic antigens, and PD-L1 expression seem to work in synergy to facilitate viral persistence in MS brains, which fuels a sustained and ineffective but detrimental inflammatory immune response, provoking tissue damage and disease progression. The gene discussed is CD274; the disease is myeloid sarcoma.